Special Issue "New Insights into Neurofibromatosis"

A special issue of Cancers (ISSN 2072-6694).

Deadline for manuscript submissions: 31 August 2019

Special Issue Editors

Guest Editor
Dr. Gelareh Zadeh

Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
Website | E-Mail
Interests: neurofibromatosis; peripheral nerve sheath tumors; meningiomas; glioblastomas
Guest Editor
Dr. Suganth Suppiah

Department of Neurosurgery, University of Toronto, Toronto, Canada
Website | E-Mail
Interests: neurofibromatosis; peripheral nerve sheath tumors; meningiomas; neurosurgery
Guest Editor
Dr. Farshad Nassiri

Division of Neurosurgery, Saint Michael's Hospital University of Toronto, Toronto, Canada
Website | E-Mail
Interests: meningiomas; glioblastomas; neurosurgery

Special Issue Information

Dear Colleagues,

The neurofibromatosis family of hereditary tumor predisposition disorders significantly impair quality-of-life and lead to early mortality through the development of innumerable nervous system tumors. In the context of neurofibromatosis type 1 (NF-1), the management of neurofibromas, malignant peripheral nerve sheath tumors (MPNSTs), and gliomas is challenging due to the limited therapeutic options. Similarly, neurofibromatosis type 2 (NF-2) and schwannomatosis lead to the development of multiple schwannomas and meningiomas within the cranial vault, spinal canal, and extremities. Over the past decade, there has been significant progress in our understanding of the molecular drivers of these tumors and the identification of potential targeted therapies. Here, we welcome papers reviewing the current state of management of these disorders and the advances in characterization of the molecular landscape of the different subtypes afflicting this population.

Dr. Gelareh Zadeh
Dr. Suganth Suppiah
Dr. Farshad Nassiri
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neurofibromatosis
  • peripheral nerve sheath tumors
  • glioblastomas
  • meningiomas

Published Papers

This special issue is now open for submission.
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top